scispace - formally typeset
M

Marc Sapoval

Researcher at University of Paris

Publications -  257
Citations -  8475

Marc Sapoval is an academic researcher from University of Paris. The author has contributed to research in topics: Embolization & Stent. The author has an hindex of 40, co-authored 235 publications receiving 7428 citations. Previous affiliations of Marc Sapoval include French Institute of Health and Medical Research & Paris Descartes University.

Papers
More filters
Journal ArticleDOI

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial

TL;DR: Catheter-based renal denervation can safely be used to substantially reduce blood pressure in treatment-resistant hypertensive patients and should be continued, according to the authors.
Journal ArticleDOI

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Michel Azizi, +132 more
- 09 Jun 2018 - 
TL;DR: In this article, the authors investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the absence of antihypertensive medications.
Journal ArticleDOI

A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low- to moderate-risk patients

TL;DR: In patients with low to intermediate risk factors, open repair of AAA is as safe as EVAR and remains a more durable option.
Journal ArticleDOI

First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension

TL;DR: Ultrasound renal denervation appears to be a safe and effective treatment for resistant hypertension and further studies will be performed to confirm these preliminary results.